Health
Alexion, AstraZeneca Rare Disease, will transition to 100% renewable energy for Ireland operations sites in 15-year biomethane gas purchase agreement
Alexion, AstraZeneca Rare Disease has announced a major clean-energy milestone, committing to 100 percent biomethane for its Dublin and Athlone sites through a 15-year partnership with Carbon AMS, marking the first large-scale biomethane adoption by a pharmaceutical company in Ireland.